Sign in
4

Changes in Ownership

Shuttle Pharmaceuticals Holdings, Inc. Filed Acc 0001493152-24-009451

Chief Financial Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Vander Hoek Michael Chief Financial Officer 2024-03-08 Grant or award +100,000 103,852 D
Loading xslF345X05/ownership.xml…